Alx Oncology Holdings (ALXO) Return on Capital Employed Growth (3y) (2023 - 2026)
Alx Oncology Holdings (ALXO) Return on Capital Employed Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,380.63 Bn | 66,380.34 Bn | - | - |
| 2 | Nanobiotix | 1,910.39 Bn | 1,910.33 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 470.95 Bn | 466.16 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.76 Bn | 50.58 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn | 4,853.00 |
| 10 | Alx Oncology Holdings | 216.17 Mn | 216.17 Mn | - | -4,266.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,266.00 |
| Dec 31, 2025 | -17,961.00 |
| Sep 30, 2025 | -14,174.00 |
| Jun 30, 2025 | -10,256.00 |
| Mar 31, 2025 | -9,172.00 |
| Dec 31, 2024 | -7,380.00 |
| Sep 30, 2024 | -7,695.00 |
| Jun 30, 2024 | -8,901.00 |
| Mar 31, 2024 | -7,748.00 |
| Dec 31, 2023 | -7,445.00 |
| Sep 30, 2023 | -5,895.00 |